Neil spent more than 30 years in corporate finance and has a broad range of transaction experience in the UK and European life sciences arena having advised on more than 150 transactions across Therapeutics, Medical Devices, Tools & Diagnostics and TechBio. He brings a wealth of experience in deal structuring, valuation and due diligence.

He was previously CEO of Piper Sandler Ltd. and Head of Piper’s European Healthcare Investment Banking business, having been with the firm for 16 years. Prior to that he worked for ING, Deutsche Bank, UBS and Hill Samuel. He graduated from Kings College, London and trained as a Chartered Accountant with Coopers & Lybrand (PWC).